- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02134561
Assessment of the Psychological, Cognitive and Social Resources of Applicants for Huntington's Disease and Presymptomatic Genetic Testing (PREHUNT)
October 20, 2020 updated by: University Hospital, Angers
The purpose of this study is to assess the psychological, cognitive and social resources of applicants for Huntington's Disease and Presymptomatic Testing.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
24
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pays De La Loire
-
Angers, Pays De La Loire, France, 49933
- University hospital of Angers
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Applicants for Huntington's Disease and Presymptomatic Testing
- Aged 18 years and above
- Huntington disease family member
- Subject gave its written consent
Exclusion Criteria:
- No national health insurance affiliation
- Being under guardianship
- Meeting brain MRI exclusion criteria (pacemakers, aneurysm clips, artificial heart valves, ear implants, metal fragments or foreign objects in the eyes, skin, or body, Renal failure, hypersensitivity of Gadolinium) or refusing MRI.
- Patient with movement disorder
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: All subjects
psychological interview, MRI, neurological tests, cognitive tests
|
This MRI is a specific intervention assign to the subjects of the study, that's why it is an interventionnal study
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change from baseline total score of the psychological Unified Huntington's Disease Rating Scale at 2 years
Time Frame: 3 months before diagnostic (baseline) ; 2 years after diagnostic,
|
3 months before diagnostic (baseline) ; 2 years after diagnostic,
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2013
Primary Completion (Actual)
August 1, 2018
Study Completion (Actual)
August 1, 2018
Study Registration Dates
First Submitted
April 10, 2014
First Submitted That Met QC Criteria
May 6, 2014
First Posted (Estimate)
May 9, 2014
Study Record Updates
Last Update Posted (Actual)
October 22, 2020
Last Update Submitted That Met QC Criteria
October 20, 2020
Last Verified
February 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Mental Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Neurocognitive Disorders
- Genetic Diseases, Inborn
- Basal Ganglia Diseases
- Movement Disorders
- Neurodegenerative Diseases
- Dyskinesias
- Heredodegenerative Disorders, Nervous System
- Dementia
- Cognition Disorders
- Chorea
- Huntington Disease
Other Study ID Numbers
- 2013-A00088-37
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Presymptomatic Huntington Disease
-
University of IowaThe University of Texas Health Science Center, Houston; Children's Hospital... and other collaboratorsActive, not recruitingJuvenile Huntington Disease | Juvenile-Onset Huntington DiseaseUnited States
-
Sanguine BiosciencesHoffmann-La RocheRecruitingHuntington Disease | Huntington's Dementia | Huntington Disease, Late Onset | Huntington; Dementia (Etiology)United States
-
AltoidaUniversity of Roma La Sapienza; Fundacion Clinic per a la Recerca Biomédica; Neuromed... and other collaboratorsCompletedCognitive Impairment | Dementia | Alzheimer Disease | Mild Cognitive Impairment | Memory Disorders | Presymptomatic Disease
-
Assistance Publique - Hôpitaux de ParisCEACompletedBrain Neuroimaging Biomarkers in Huntington DiseaseFrance
-
European Huntington's Disease NetworkCompletedHuntington Disease, JuvenileGermany, United Kingdom
-
PrileniaCompletedHealth Volunteers, Huntington DiseaseGermany
-
Novartis PharmaceuticalsTerminatedEarly Manifest Huntington DiseaseCanada, Germany, France, Spain, Hungary
-
Neurocrine BiosciencesHuntington Study GroupActive, not recruitingChorea, HuntingtonUnited States, Canada
-
Neurocrine BiosciencesHuntington Study GroupCompletedChorea, HuntingtonUnited States, Canada
-
Auspex Pharmaceuticals, Inc.CompletedChorea Associated With Huntington DiseaseUnited States, Australia, Canada
Clinical Trials on psychological interview
-
University Hospital, GrenobleRegional Council of Auvergne-Rhône-AlpesTerminatedTraumatic Brain InjuryFrance
-
Direction Centrale du Service de Santé des ArméesRecruitingPost-traumatic Stress DisorderFrance
-
Assistance Publique - Hôpitaux de ParisNot yet recruiting
-
University Hospital, AngersTerminated
-
University Hospital, Montpellierfondation john bostNot yet recruitingPsychotic Disorders | Schizophrenia | Cognitive Impairment | MotivationFrance
-
Technische Universität DresdenCharite University, Berlin, Germany; Central Institute of Mental Health, MannheimRecruitingAlcoholism | Substance Use Disorders | Alcohol Use Disorder (AUD)Germany
-
Institut de Cancérologie de LorraineCompleted
-
Technische Universität DresdenCharite University, Berlin, Germany; Central Institute of Mental Health, MannheimRecruitingAlcoholism | Methamphetamine-dependence | Substance Use Disorders | Cocaine Use Disorder | Alcohol Use Disorder (AUD) | Cannabis Use Disorder | Amphetamine Use DisorderGermany
-
Centre Hospitalier Universitaire de BesançonUnknownPrimary Headache DisorderFrance
-
University of North Carolina, Chapel HillNational Institute on Drug Abuse (NIDA); National Institute on Alcohol Abuse... and other collaboratorsCompleted